1. The Proprotein Convertase SKI-1/S1P
- Author
-
Nabil G. Seidah, Monica Dettin, Carlo Di Bello, Francesca Ghezzo, M. Vacatello, Livio Paolillo, Federica Basso, Antonella Pasquato, Marie-Claude Asselin, and Philomena Pullikotil
- Subjects
chemistry.chemical_classification ,Mutant ,Peptide ,Cell Biology ,Biology ,Proprotein convertase ,medicine.disease_cause ,Biochemistry ,Molecular biology ,In vitro ,Lassa virus ,chemistry ,medicine ,biology.protein ,Glycoprotein ,Molecular Biology ,Furin ,Ex vivo - Abstract
Herein we designed, synthesized, tested, and validated fluorogenic methylcoumarinamide (MCA) and chloromethylketone-peptides spanning the Lassa virus GPC cleavage site as substrates and inhibitors for the proprotein convertase SKI-1/S1P. The 7-mer MCA (YISRRLL-MCA) and 8-mer MCA (IYISRRLL-MCA) are very efficiently cleaved with respect to both the 6-mer MCA (ISRRLL-MCA) and point mutated fluorogenic analogues, except for the 7-mer mutant Y253F. The importance of the P7 phenylic residue was confirmed by digestions of two 16-mer non-fluorogenic peptidyl substrates that differ by a single point mutation (Y253A). Because NMR analysis of these 16-mer peptides did not reveal significant structural differences at recognition motif RRLL, the P7 Tyr residue is likely important in establishing key interactions within the catalytic pocket of SKI-1. Based on these data, we established through analysis of pro-ATF6 and pro-SREBP-2 cellular processing that decanoylated chloromethylketone 7-mer, 6-mer, and 4-mer peptides containing the core RRLL sequence are irreversible and potent ex vivo SKI-1 inhibitors. Although caution must be exercised in using these inhibitors in in vitro reactions, as they can also inhibit the basic amino acid-specific convertase furin, within cells and when used at concentrations < or = 100 microM these inhibitors are relatively specific for inhibition of SKI-1 processing events, as opposed to those performed by furin-like convertases.
- Published
- 2006
- Full Text
- View/download PDF